TerminatedNot Applicable

Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Epilepsy

Stopped: Lack of recruitement and finalisation of research on this topic by investigator

Belgium4 participantsStarted 2015-02-03

Plain-language summary

The purpose of this study is to assess the effects of repetitive transcranial magnetic stimulation (rTMS) as a treatment for Epilepsia Partialis Continua (EPC) or refractory Status Epilepticus (SE), when standard clinical treatments have failed.

Who can participate

Age range

18 Years – 75 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Epilepsia partialis continua or refractory status epilepticus * Prior investigations (EEG, MRI...) show a well-defined neocortical epileptogenic focus * Informed consent signed by the patient or his/her legal representative Exclusion Criteria: * Pregnancy, short-term birth wish or childbearing age without adequate birth control * Intracranial metal hardware (excluding dental filling): surgical clips, shrapnell, electrodes under the stimulation area * Presence of pacemaker, implantable cardioverter-defibrillator (ICD), permanent medication pumps, cochlear implants or deep brain stimulation (DBS)

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Seizure diary

Timeframe: Throughout the study, lasting approximately 4 weeks

Electrographic epileptiform activity

Timeframe: Throughout the study, lasting approximately 4 weeks, with assessment before treatment (if possible) and after treatment

Neurological examination

Timeframe: Throughout the study, lasting approximately 4 weeks

Trial details

NCT IDNCT02560597

SponsorUniversity Hospital, Ghent

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-03

View on ClinicalTrials.gov More Epilepsia Partialis Continua trials

Who can participate

Age range

18 Years – 75 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Seizure diary

Timeframe: Throughout the study, lasting approximately 4 weeks

Electrographic epileptiform activity

Timeframe: Throughout the study, lasting approximately 4 weeks, with assessment before treatment (if possible) and after treatment

Neurological examination

Timeframe: Throughout the study, lasting approximately 4 weeks